We sat down with Pro Medicus CEO, Dr Sam Hupert on results day to discuss the past six months and the all-important outlook.
CSL, in contrast, has stagnated for five years, underperforming the ASX200 by 22% in the past year. Its latest earnings miss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback